ORBITAL SCIENCES CORP /DE/ Spending and interest coverage
- R&D / revenue · 12 months: Value 2.40%; Formula and calculation Research and development expense / revenue. Period ending 2014-09-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2014-09-30..
- Interest coverage · 12 months: Value 23.14×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2014-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.40% | Research and development expense / revenue. Period ending 2014-09-30. $32.54M ÷ $1.36B × 100 ≈ 2.40% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2014-09-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | 23.14× | Operating income ÷ reported interest expense. $102.03M ÷ $4.41M ≈ 23.14× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 32.54M USD | Research and Development Expense |
| Revenue | 1.36B USD | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 102.03M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 4.41M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $32.54M | $1.36B | (m) | $102.03M | $4.41M | 2.40% | (m) | 23.14× | Reported |
| 2014-06-30 | $48.17M | $1.34B | (m) | $94.37M | $4.47M | 3.60% | (m) | 21.10× | Reported |
| 2014-03-31 | $63.97M | $1.35B | (m) | $105.42M | $4.55M | 4.73% | (m) | 23.18× | Reported |
| 2013-12-31 | $89.23M | $1.37B | $7.72M | $113.55M | $4.56M | 6.54% | 0.57% | 24.92× | Reported |
| 2013-09-30 | $109.95M | $1.34B | (m) | $114.34M | $6.15M | 8.18% | (m) | 18.59× | Reported |
| 2013-06-30 | $119.72M | $1.40B | (m) | $120.05M | $7.52M | 8.58% | (m) | 15.96× | Reported |
| 2013-03-31 | $118.46M | $1.43B | (m) | $119.83M | $9.31M | 8.26% | (m) | 12.87× | Reported |
| 2012-12-31 | $114.20M | $1.44B | $6.40M | $112.57M | $11.28M | 7.95% | 0.45% | 9.98× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $1.35B | (m) | $79.79M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.29B | (m) | $73.01M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $109.75M | $1.13B | $9.24M | $52.29M | $9.04M | 9.75% | 0.82% | 5.79× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $51.41M | $1.17B | $9.28M | $84.28M | $-8.77M | 4.40% | 0.79% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.